A5061947234- Peripheral Artery Disease Management
- Cerebrovascular and Carotid Artery Diseases
- Diagnosis and Treatment of Venous Diseases
- Acute Ischemic Stroke Management
- Venous Thromboembolism Diagnosis and Management
- Antiplatelet Therapy and Cardiovascular Diseases
- Pain Management and Treatment
- Diabetic Foot Ulcer Assessment and Management
- Cardiac Health and Mental Health
- Health Systems, Economic Evaluations, Quality of Life
- Atrial Fibrillation Management and Outcomes
- Clinical practice guidelines implementation
- Vascular Procedures and Complications
- Cardiac, Anesthesia and Surgical Outcomes
- Cardiovascular Health and Disease Prevention
- Stroke Rehabilitation and Recovery
- Cardiac Arrhythmias and Treatments
- Vasculitis and related conditions
- Obesity and Health Practices
- Health and Wellbeing Research
- Obstructive Sleep Apnea Research
- Nursing education and management
- Dietetics, Nutrition, and Education
- Telemedicine and Telehealth Implementation
- Cardiovascular Health and Risk Factors
Yale University
2021-2025
Lindsey Wilson College
2016-2023
Yale New Haven Hospital
2017-2020
Quinnipiac University
2014-2017
St. Vincent's Medical Center
2017
ABSTRACT Background Evaluating health status changes following transfemoral carotid artery stenting (TF‐CAS) is essential for assessing procedural success, but meaningful clinical are unknown. We aimed to determine minimal clinically important differences (MCIDs) and quantify improvement or worsening rates after TF‐CAS using the Stenting Angioplasty with Protection in Patients at High Risk Endarterectomy (SAPPHIRE) registry data. Methods The SAPPHIRE included patients undergoing from 2010...
Introduction: Reintervention following peripheral vascular intervention (PVI) for artery disease (PAD) is common. Guideline-directed medical therapy (GDMT) recommended post-PVI, yet its association with reintervention outcomes remains unclear. Methods: We analyzed Vascular Quality Initiative registry data linked Medicare outcome patients undergoing PVI PAD (2017–2018). GDMT was defined as the receipt of statin, antiplatelet, and angiotensin-converting enzyme or angiotensin receptor blocker...
Background Peripheral artery disease (PAD) and microvascular (MVD) are highly prevalent conditions that share common risk factors. This observational study aimed to characterize patients with both determine the impact of comorbid PAD/MVD on outcomes. Methods Results Patients admitted across 31 states January 2011 through December 2018 a primary or secondary diagnosis PAD MVD were included from National Readmissions Database weighted approximate national sample. Those age <18 years...
Introduction: Patients with chronic limb-threatening ischemia (CLTI) have high mortality rates after revascularization. Risk stratification for short-term outcomes is challenging. We aimed to develop machine-learning models rank predictive variables 30-day and 90-day all-cause peripheral vascular intervention (PVI). Methods: undergoing PVI CLTI in the Medicare-linked Vascular Quality Initiative were included. Sixty-six preprocedural Random survival forest (RSF) constructed training sample...
Patients with chronic limb-threatening ischemia (CLTI) face a high long-term mortality risk. Identifying novel predictors and risk profiles would enable individual health care plan design improved survival. We aimed to leverage random survival forest machine-learning algorithm identify all-cause in patients CLTI undergoing peripheral vascular intervention.
While nutritional interventions are first-line therapy for many chronic diseases, most medical trainees receive minimal nutrition education, leaving them unprepared to address issues with patients. An interactive, single-session, virtual curriculum was taught online 80 physician assistant (PA) students. Topics included plant-based nutrition, dietary history-taking and counseling, culinary medicine. Students were surveyed before, immediately after, four weeks after the assess changes...
Critical limb ischemia (CLI), the most severe form of peripheral artery disease, is associated with pain, poor wound healing, high rates amputation, and mortality (>20% at 1 year). Little known about processes care, patients' preferences, or outcomes, as seen from perspectives. The SCOPE-CLI study was co-designed patients to holistically document patient characteristics, treatment patterns patient-centered outcomes for CLI. This 11-center prospective observational registry will enroll...
Background Sleep apnea is a predictor of adverse cardiovascular outcome in many diseases but whether it associated with worse health status outcomes or mortality peripheral artery disease (PAD) unknown. Methods PORTRAIT an international (US, Netherlands, Australia) prospective PAD registry that consecutively enrolled patients who presented new-onset recent exacerbations symptoms to any 16 vascular specialty clinics. Health was assessed upon presentation and at 12 months the disease-specific...
Objectives Antiplatelet therapy is an essential element in the management of patients with arterial vascular disease. In peripheral disease (PAD), dual antiplatelet (DAPT), primarily clopidogrel and aspirin, routinely prescribed following intervention. There sparse data regarding need for DAPT, appropriate duration, or heterogeneity treatment effects regimens across patients, leading to potential uncertainty around practices. An example a patients’ metabolizer status use clopidogrel. The aim...